This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_INTESTINEOTH_EXALLC for full statistics.
Carcinoma in situ of other and unspecified parts of intestine
CD2_INSITU_INTESTINEOTH
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
5 |
4. Check minimum number of eventsNone |
5 |
5. Include endpointsNone |
5 |
6. Filter based on genotype QC (FinnGen only) |
5 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D01
- Name in latin
- Carcinoma in situ partium aliarum sive non specificatarum intestini
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of other and unspecified parts of intestine
based on the number of shared cases.
Similar with more cases:
- Carcoma in situ of toher and unspecified parts of intestine
- Carcinoma in situ of other and unspecified digestive organs
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 57.54 | - | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5
32
+∞
0.80
5.6
7.7
u/l
254.4
91.4
—
5
32
(3012516) Albumin [Mass/volume] in Urine
0
11
0.00
0.24
0.0
3.6
—
32.5
—
0
6
(3020564) Creatinine [Moles/volume] in Serum or Plasma
5
40
+∞
0.24
18.2
20.1
umol/l
68.8
79.7
—
5
40
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.24
0.0
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
0
10
0.00
0.24
0.0
2.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5
38
+∞
0.24
19.4
14.4
mg/l
32.6
15.9
—
5
28
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
0
9
0.00
0.24
0.0
2.6
—
1.0
—
0
9
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
5
44
+∞
0.00
27.8
21.0
g/l
120.4
133.9
—
5
44
(36304419) Bacteria [Presence] in Urine
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
8.2
—
0
7
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024731) MCV [Entitic volume]
5
44
+∞
0.00
27.6
20.8
fl
92.5
91.6
—
5
44
(3000850) Epithelial cells [#/volume] in Urine
0
6
0.00
0.00
0.0
2.3
—
6.0
—
0
6
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012544) pH of Venous blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
5
44
+∞
0.00
27.6
20.8
pg
30.7
30.5
—
5
44
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.8
—
0.2
—
0
5
(40761511) CBC panel - Blood by Automated count
5
42
+∞
0.00
16.8
13.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
6
0.00
0.00
0.0
2.5
—
4.8
—
0
6
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.0
—
60.9
—
0
5
(3024354) Oxygen [Partial pressure] in Venous blood
0
5
0.00
0.00
0.0
2.6
—
4.2
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_INTESTINEOTH – Carcinoma in situ of other and unspecified parts of intestine
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).